Differential Selectivity of Natural and Synthetic Aminoglycosides towards the Eukaryotic and Prokaryotic Decoding A Sites

No abstract is available for this paper.

• Publication year

  2007

• Venue

  ChemBioChem

• Publication date

  2007-09-24

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/cbic.200700271PMID 17705310
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure-Based Design, Synthesis, and A-Site rRNA Cocrystal Complexes of Functionally Novel Aminoglycoside Antibiotics: C2'' Ether Analogues of Paromomycin

  2007cited by this paper
• Structure-based design, synthesis, and A-site rRNA cocrystal complexes of functionally novel aminoglycoside antibiotics: C2" ether analogues of paromomycin.

  2007cited by this paper
• Apramycin recognition by the human ribosomal decoding site.

  2007cited by this paper
• Interactions of designer antibiotics and the bacterial ribosomal aminoacyl-tRNA site.

  2006cited by this paper
• Novel aminoglycosides increase SMN levels in spinal muscular atrophy fibroblasts

  2006cited by this paper
• Redesign of aminoglycosides for treatment of human genetic diseases caused by premature stop mutations.

  2006cited by this paper
• Crystal structure of the Homo sapiens cytoplasmic ribosomal decoding site complexed with apramycin.

  2006cited by this paper
• Two conformational states in the crystal structure of the Homo sapiens cytoplasmic ribosomal decoding A site

  2006cited by this paper
• Aminoglycoside‐Hybrid Ligands Targeting the Ribosomal Decoding Site

  2005cited by this paper
• Pharmacological Suppression of Premature Stop Mutations that Cause Genetic Diseases

  2005cited by this paper
• Molecular recognition by glycoside pseudo base pairs and triples in an apramycin-RNA complex.

  2005cited by this paper
• Defining the basis for the specificity of aminoglycoside-rRNA recognition: a comparative study of drug binding to the A sites of Escherichia coli and human rRNA.

  2005cited by this paper
• Crystal structures of complexes between aminoglycosides and decoding A site oligonucleotides: role of the number of rings and positive charges in the specific binding leading to miscoding

  2005cited by this paper
• Branched aminoglycosides: biochemical studies and antibacterial activity of neomycin B derivatives.

  2005cited by this paper
• Molecular recognition of RNA by neomycin and a restricted neomycin derivative.

  2005cited by this paper
• Mapping glycoside hydrolase substrate subsites by isothermal titration calorimetry.

  2004cited by this paper
• Antibacterial aminoglycosides with a modified mode of binding to the ribosomal-RNA decoding site.

  2004cited by this paper
• Pharmacologic therapy for stop mutations: how much CFTR activity is enough?

  2004cited by this paper
• Targeting RNAs with tobramycin analogues.

  2004cited by this paper
• Fluorescence-based approach for detecting and characterizing antibiotic-induced conformational changes in ribosomal RNA: comparing aminoglycoside binding to prokaryotic and eukaryotic ribosomal RNA sequences.

  2004cited by this paper
• Effects of essential carbohydrate/aromatic stacking interaction with Tyr100 and Phe259 on substrate binding of cyclodextrin glycosyltransferase from alkalophilic Bacillus sp. 1011.

  2003cited by this paper
• Bulk-solvent correction for fast translation search in molecular replacement: service programs for AMoRe and CNS

  2003cited by this paper
• Crystal structure of geneticin bound to a bacterial 16S ribosomal RNA A site oligonucleotide.

  2003cited by this paper
• Piperidine Glycosides Targeting the Ribosomal Decoding Site

  2003cited by this paper
• Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations.

  2003cited by this paper
• A new class of branched aminoglycosides: pseudo-pentasaccharide derivatives of neomycin B.

  2003cited by this paper
• Novel Paromamine Derivatives Exploring Shallow‐Groove Recognition of Ribosomal‐ Decoding‐Site RNA

  2002cited by this paper
• Design of novel antibiotics that bind to the ribosomal acyltransfer site.

  2002cited by this paper
• Crystal structure of a complex between the aminoglycoside tobramycin and an oligonucleotide containing the ribosomal decoding a site.

  2002cited by this paper
• On the use of low-resolution data for translation search in molecular replacement.

  2002cited by this paper
• Design, modeling and synthesis of functionalized paromamine analogs

  2001cited by this paper
• Usher syndrome: from genetics to pathogenesis.

  2001cited by this paper
• Recognition of Cognate Transfer RNA by the 30S Ribosomal Subunit

  2001cited by this paper
• Mutations of the protocadherin gene PCDH15 cause Usher syndrome type 1F.

  2001cited by this paper
• Crystal structure of paromomycin docked into the eubacterial ribosomal decoding A site.

  2001cited by this paper
• Structural basis for selectivity and toxicity of ribosomal antibiotics

  2001cited by this paper
• Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system.

  2000cited by this paper
• Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics

  2000cited by this paper
• Recognition of the codon-anticodon helix by ribosomal RNA.

  1999cited by this paper
• Design and Synthesis of New Aminoglycoside Antibiotics Containing Neamine as an Optimal Core Structure: Correlation of Antibiotic Activity with in Vitro Inhibition of Translation

  1999cited by this paper
• Determinants of aminoglycoside-binding specificity for rRNA by using mass spectrometry.

  1999cited by this paper
• Correction of genetic disease by making sense from nonsense.

  1999cited by this paper
• Aminoglycoside binding to the hammerhead ribozyme: a general model for the interaction of cationic antibiotics with RNA.

  1998cited by this paper
• rRNA chemical groups required for aminoglycoside binding.

  1998cited by this paper
• Saccharide–RNA recognition

  1998cited by this paper
• An antibiotic-binding motif of an RNA fragment derived from the A-site-related region of Escherichia coli 16S rRNA.

  1996cited by this paper
• The CCP4 suite: programs for protein crystallography.

  1994cited by this paper
• Interactions of a small RNA with antibiotic and RNA ligands of the 30S subunit

  1994cited by this paper
• AMoRe: an automated package for molecular replacement

  1994cited by this paper
• Free R value: a novel statistical quantity for assessing the accuracy of crystal structures

  1992cited by this paper
• Free R value: a novel statistical quantity for assessing the accuracy of crystal structures.

  1992cited by this paper
• Interaction of antibiotics with A‐ and P‐site‐specific bases in 16S ribosomal RNA.

  1991cited by this paper
• Mechanism of bactericidal action of aminoglycosides

  1987cited by this paper
• Interaction of antibiotics with functional sites in 16S ribosomal RNA

  1987cited by this paper
• Suppression of a nonsense mutation in mammalian cells in vivo by the aminoglycoside antibiotics G-418 and paromomycin.

  1985cited by this paper
• Mechanisms of action of aminoglycoside antibiotics in eucaryotic protein synthesis

  1984cited by this paper
• Fidelity of the eukaryotic codon-anticodon interaction: interference by aminoglycoside antibiotics.

  1984cited by this paper
• Effects of apramycin, a novel aminoglycoside antibiotic on bacterial protein synthesis.

  1979cited by this paper
• Dual interference of hygromycin B with ribosomal translocation and with aminoacyl-tRNA recognition.

  1978cited by this paper
• Studies on the mode of action of hygromycin B, an inhibitor of translocation in eukaryotes.

  1978cited by this paper
• Aminoglycoside antibiotics and eukaryotic protein synthesis: stimulation of errors in the translation of natural messengers in extracts of cultured human cells.

  1978cited by this paper
• Mistranslation in E. coli.

  1977cited by this paper

• siRNA Interaction and Transfection Properties of Polycationic Phosphorus Dendrimers

  2025cites this paper
• Statistical Molecular Interaction Fields: A Fast and Informative Tool for Characterizing RNA and Protein Binding Pockets

  2025cites this paper
• Cytotoxic and Antibacterial Activity of Koninginins Isolated from the Mangrove-Derived Endophytic Fungus Trichoderma sp.

  2024cites this paper
• Influence of ring size in conformationally restricted ring I analogs of paromomycin on antiribosomal and antibacterial activity.

  2021cites this paper
• Understanding the characteristics of nonspecific binding of drug-like compounds to canonical stem–loop RNAs and their implications for functional cellular assays

  2020cites this paper
• Revealing the high propensity of RNAs to non-specifically bind drug-like small molecules

  2020cites this paper
• Small molecule-RNA targeting: starting with the fundamentals.

  2020cites this paper
• Translational readthrough inducing drugs for the treatment of inherited retinal dystrophies

  2020influential citation
• Translational read-through inducing drugs for the treatment of inherited 1 retinal dystrophies

  2020cites this paper
• Towards Catalytic Antibiotics: Redesign of Aminoglycosides To Catalytically Disable Bacterial Ribosomes

  2019cites this paper
• Comprehensive review of chemical strategies for the preparation of new aminoglycosides and their biological activities.

  2018cites this paper
• Characterization of new-generation aminoglycoside promoting premature termination codon readthrough in cancer cells

  2017cites this paper
• Atomic resolution snapshot of Leishmania ribosome inhibition by the aminoglycoside paromomycin

  2017cites this paper
• Mechanism and evidence of nonsense suppression therapy for genetic eye disorders

  2017cites this paper
• Atomic resolution snapshot of Leishmania ribosome inhibition by the aminoglycoside paromomycin

  2017cites this paper
• A structural basis for the antibiotic resistance conferred by an N1-methylation of A1408 in 16S rRNA

  2017cites this paper
• Small Molecule-Based Pattern Recognition To Classify RNA Structure.

  2017cites this paper
• Impact of Linker Length and Composition on Fragment Binding and Cell Permeation: Story of a Bisbenzimidazole Dye Fragment.

  2017cites this paper
• Title : Mechanism and evidence of nonsense suppression therapy for genetic eye 1 disorders 2 3

  2017cites this paper
• Binding thermodynamics of paromomycin, neomycin, neomycin‐dinucleotide and ‐diPNA conjugates to bacterial and human rRNA

  2016influential citation
• Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation.

  2016cites this paper
• A review of patents (2011-2015) towards combating resistance to and toxicity of aminoglycosides.

  2016cites this paper
• Nonsense Suppression as an Approach to Treat Lysosomal Storage Diseases

  2016cites this paper
• Crystallographic Studies of the Ribosomal A-Site Molecular Switches by Using Model RNA Oligomers.

  2016cites this paper
• Structural basis for selective targeting of leishmanial ribosomes: aminoglycoside derivatives as promising therapeutics

  2015cites this paper
• Conformational dynamics of bacterial and human cytoplasmic models of the ribosomal A-site.

  2015cites this paper
• Synthesis and Antiribosomal Activities of 4'-O-, 6'-O-, 4″-O-, 4',6'-O- and 4″,6″-O-Derivatives in the Kanamycin Series Indicate Differing Target Selectivity Patterns between the 4,5- and 4,6-Series of Disubstituted 2-Deoxystreptamine Aminoglycoside Antibiotics.

  2015cites this paper
• Rigid spiroethers targeting the decoding center of the bacterial ribosome.

  2014cites this paper
• When Proteins Start to Make Sense: Fine-tuning Aminoglycosides for PTC Suppression Therapy.

  2014cites this paper
• Role of S-turn2 in the structure, dynamics, and function of mitochondrial ribosomal A-site. A bioinformatics and molecular dynamics simulation study.

  2014cites this paper
• 23. RNA Crystallization

  2014cites this paper
• Crystal Structures of a Bioactive 6′‐Hydroxy Variant of Sisomicin Bound to the Bacterial and Protozoal Ribosomal Decoding Sites

  2013cites this paper
• Recent developments on synthetic tools towards structural and functional glycodiversity.

  2013cites this paper
• Designer Aminoglycosides That Selectively Inhibit Cytoplasmic Rather than Mitochondrial Ribosomes Show Decreased Ototoxicity

  2013cites this paper
• Identification of the molecular attributes required for aminoglycoside activity against Leishmania

  2013cites this paper
• Aminoglycoside Antibiotics: Structural Decoding of Inhibitors Targeting the Ribosomal Decoding A Site

  2013cites this paper
• Investigations of the Natural Product Antibiotic Thiostrepton from Streptomyces azureus and Associated Mechanisms of Resistance

  2013cites this paper
• Polymyxins and Analogues Bind to Ribosomal RNA and Interfere with Eukaryotic Translation in Vitro

  2013cites this paper
• Rise and dissemination of aminoglycoside resistance: the aac(6′)-Ib paradigm

  2013cites this paper
• Increased selectivity toward cytoplasmic versus mitochondrial ribosome confers improved efficiency of synthetic aminoglycosides in fixing damaged genes: a strategy for treatment of genetic diseases caused by nonsense mutations.

  2012cites this paper
• 4.1. Aminoglycoside Antibiotics

  2012cites this paper
• Pharmaceuticals Targeting Nonsense Mutations in Genetic Diseases

  2012cites this paper
• Crystal structure and specific binding mode of sisomicin to the bacterial ribosomal decoding site.

  2012cites this paper
• Myotonic dystrophy type 1 RNA crystal structures reveal heterogeneous 1 × 1 nucleotide UU internal loop conformations.

  2011cites this paper
• A Homo sapiens cytoplasmic ribosomal decoding A-site affinity screen evaluating aminoglycoside and analogue binding.

  2011cites this paper
• Repairing faulty genes by aminoglycosides: Identification of new pharmacophore with enhanced suppression of disease-causing nonsense mutations

  2011cites this paper
• Method Development And Applications To Screening And Characterization Of Rrna-Targeting Small Molecules

  2011cites this paper
• Identification of RNA-ligand interactions by affinity electrophoresis.

  2011cites this paper
• Designed Spiro‐Bicyclic Analogues Targeting the Ribosomal Decoding Center

  2011cites this paper
• Antibiotics that target protein synthesis

  2011cites this paper
• The Future of Aminoglycosides: The End or Renaissance?

  2010cites this paper
• Tether influence on the binding properties of tRNALys3 ligands designed by a fragment-based approach.

  2010cites this paper
• Aminoglycosides redesign strategies for improved antibiotics and compounds for treatment of human genetic diseases.

  2010influential citation
• Repairing faulty genes by aminoglycosides: development of new derivatives of geneticin (G418) with enhanced suppression of diseases-causing nonsense mutations.

  2010cites this paper
• 8.13 – Enzymology of Bacterial Resistance

  2010cites this paper
• Strategies for the design of RNA-binding small molecules.

  2010cites this paper
• Tetracycline, Aminoglycoside, Macrolide, and Miscellaneous Antibiotics

  2010cites this paper
• Unnatural Rigid Scaffolds Targeting the Bacterial Ribosome

  2009cites this paper
• The use of ribosomal crystal structures in antibiotic drug design.

  2009cites this paper
• Base pairs and pseudo pairs observed in RNA–ligand complexes

  2009cites this paper
• Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations.

  2009cites this paper
• G 418-mediated ribosomal read-through of a nonsense mutation causing autosomal recessive proximal renal tubular acidosis

  2008cites this paper
• G418-mediated ribosomal read-through of a nonsense mutation causing autosomal recessive proximal renal tubular acidosis.

  2008cites this paper
• Designer aminoglycosides: the race to develop improved antibiotics and compounds for the treatment of human genetic diseases.

  2008cites this paper